Precision System Science Co Stock

Precision System Science Co EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Precision System Science Co (7707.T) as of Jul 22, 2026 is -50.10. In the previous year, EV/EBIT (Enterprise Value to EBIT) was -6.37 — a change of 687.07% (lower).

EV/EBIT

-50.10

YoY

687.07%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Precision System Science Co is 2026 -50.10 . EV/EBIT (Enterprise Value to EBIT) of Precision System Science Co was 2025 -6.37 . It decreases by 687.07% lower compared to the previous year.

The Precision System Science Co EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2019
56.52 base
Jan 1, 2020
-301.91 base
Jan 1, 2021
14.82 base
Jan 1, 2022
77.07 base
Jan 1, 2023
-6.46 base
Jan 1, 2024
-6.65 base
Jan 1, 2025
-42.09 base
Jan 1, 2026 (e)
0.00 base
YEARPRICE-TO-EBIT
2026 est -
2025 -42.09
2024 -6.65
2023 -6.46
2022 77.07
2021 14.82
2020 -301.91
2019 56.52
2018 -16.03
2017 -31.44
2016 -11.15
2015 -32.68
2014 -21.01
2013 -128.14
2012 -21.85
2011 -6.17
2010 4.54
2009 19.84
2008 -5.68
2007 -32.43
2006 372.99
Access this data via the Eulerpool API

Precision System Science Co Valuation

Details

Historical Valuation Multiples

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Precision System Science Co's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Precision System Science Co's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Precision System Science Co's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Precision System Science Co grows earnings faster than its peers.

Precision System Science Co Stock analysis

What does Precision System Science Co do? Precision System Science Co Ltd is a leading company in the field of medical research and diagnostics, founded in Japan in 1989. The company is headquartered in Chiba, Japan and operates branches in Europe, the USA, and Asia. Its business model is focused on providing a wide range of instruments, devices, and services for research, diagnostics, and therapy in the medical industry. The company designs and produces its own products and also offers customized solutions for customers. It is divided into different divisions, including instruments and devices for molecular biology and diagnostics, cell analysis, microscopy, and sample processing. They offer products such as PCR systems, qPCR systems, automated sample preparation systems, and RNA isolation kits for molecular biology and diagnostics. They also produce cell counting systems, flow cytometers, high-speed imaging systems, multi-well plate readers for cell analysis. In the microscopy division, the company manufactures high-quality fluorescence microscopes and deconvolution microscopes for protein and DNA molecule analysis, disease diagnostics, drug development, etc. In the sample processing division, they produce automated stations used for preparing samples for genomics and proteomics analysis. The company is also engaged in research and development of medical devices and instruments to improve the quality of medical diagnostics and therapy. A successful product example is the qPCR thermocycler MIQE used in the diagnosis and therapy of diseases like cancer. Precision System Science Co Ltd has played a significant role in fighting the COVID-19 pandemic by producing test kits for diagnosis and offering advanced PCR systems for mass testing. They are committed to continuous innovation and improvement of their products and services to meet the changing needs of the medical industry. With their strong presence and dedication to providing state-of-the-art and innovative products and services, they will remain a major player in the global market for medical devices and instruments. Precision System Science Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Precision System Science Co stock

EV/EBIT (Enterprise Value to EBIT) of Precision System Science Co is -50.10 in 2026.

Access this data via the Eulerpool API

Valuation — Precision System Science Co

All Key Metrics — Precision System Science Co